Genosys Biotechnologies

Genosys Biotechnologies was a pioneering life sciences company specializing in the custom synthesis of oligonucleotides and peptides. The company gained prominence for developing proprietary high-throughput synthesis technologies that made synthetic DNA more accessible and affordable for researchers worldwide. In 1998, Genosys was acquired by Sigma-Aldrich, leading to the formation of Sigma-Genosys and significantly expanding Sigma's presence in the molecular biology market. The company's operations and technologies are now part of MilliporeSigma, the life science business of Merck KGaA. They continue to support genomic research and diagnostic development through their legacy platforms. Genosys is recognized for its historical role in standardizing the commercial production of DNA primers.